Cargando…
Will vaccine-derived protective immunity curtail COVID-19 variants in the US?
Multiple effective vaccines are currently being deployed to combat the COVID-19 pandemic, and are viewed as the major factor in marked reductions of disease burden in regions with moderate to high vaccination coverage. The effectiveness of COVID-19 vaccination programs is, however, significantly thr...
Autores principales: | Mancuso, Marina, Eikenberry, Steffen E., Gumel, Abba B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426325/ https://www.ncbi.nlm.nih.gov/pubmed/34518808 http://dx.doi.org/10.1016/j.idm.2021.08.008 |
Ejemplares similares
-
Dynamics of COVID-19 pandemic in India and Pakistan: A metapopulation modelling approach
por: Brozak, Samantha J., et al.
Publicado: (2021) -
Optimizing COVID-19 vaccination programs during vaccine shortages
por: Liu, Kaihui, et al.
Publicado: (2022) -
Vaccine efficacy and SARS-CoV-2 control in California and U.S. during the session 2020–2026: A modeling study
por: Mahmud, Md Shahriar, et al.
Publicado: (2021) -
Switched forced SEIRDV compartmental models to monitor COVID-19 spread and immunization in Italy
por: Antonelli, Erminia, et al.
Publicado: (2021) -
Large-scale frequent testing and tracing to supplement control of Covid-19 and vaccination rollout constrained by supply
por: Humphrey, Lia, et al.
Publicado: (2021)